To determine whether those 5 FR-DELs (DOCK8-AS1, SNHG17, RUSC1-AS1, LINC02609, and LUCAT1) could be prognosis signatures for renal cancer, we used the validation group data and entire group data for verification. This evidence concerns the gene LUCAT1 and renal carcinoma.